# China NMPA Drug Inspection - Shandong Yikang Pharmaceutical Co., Ltd. - Amoxicillin granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shandong-yikang-pharmaceutical-co-ltd/ec055583-ba79-4690-8f4d-6122c46ee616/
Source feed: China

> China NMPA drug inspection for Shandong Yikang Pharmaceutical Co., Ltd. published November 11, 2021. Drug: Amoxicillin granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Shandong Yikang Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Amoxicillin granules
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/shandong-yikang-pharmaceutical-co-ltd/c3365e39-befc-4a14-a416-83e11add2e36/